Voyager registers $86.25 million of stock for initial public offering

Cowen, Piper Jaffray, Nomura and Wedbush PacGrow will assist with deal

By Devika Patel

Knoxville, Tenn., Oct. 9 – Voyager Therapeutics, Inc. will price its initial public sale of common stock with a 30-day greenshoe, according to a Form S-1 filed Friday with the Securities and Exchange Commission. The company has registered up to $86.25 million of stock.

Cowen and Co. and Piper Jaffray are the bookrunners. Nomura is the lead manager, and Wedbush PacGrow is the co-manager.

Proceeds will be used for clinical development, clinical trials, preclinical development, working capital and other general corporate purposes.

The clinical-stage gene therapy company is based in Cambridge, Mass. The company intends to list its common stock on the Nasdaq stock exchange under the symbol “VYGR.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.